Trials / Terminated
TerminatedNCT00681512
The Effect of Berries on Lung Cancer Tumors
Berry Interventional Trial (BIT) in Resected Non-Small Cell Lung Cancer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.
Detailed description
In the United States, more people (161,840 per year) die of lung cancers than of prostate cancer, breast cancer and colon cancer combined. Presently, there are over 43 million current smokers and over 47 million ex-smokers living in the US. Due to the lag time between smoking and the development of cancer, there are significant numbers of ex-smokers and current smokers who may develop lung cancer compared to never smokers. Recent studies in animals have shown that berries, given as a dietary supplement, are highly effective against certain types of cancers. In a study involving mice with lung tumors, mice that had consumed a mixture of berries developed fewer tumors and had less tumor growth than mice that did not consume berries. The berries used in this study will consist of blueberries, black raspberries, or a mixture of both.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | berry powder | All subjects (lung cancer survivors and volunteers) will consume 20 grams of berry powder (blueberries, black raspberries, or a mixture of both) per day by mouth for the first 3 days, then 40 grams of berry powder by mouth every day for 4 to 5 weeks. The berry powder is to be mixed in subject's routine intake of milk, yogurt, juice, or water. All subjects will have the option to continue the berry regimen for an extended period. Subjects who choose to do so will not consume any berry powder for one week. After one week, subjects will begin consuming 40 grams of the berry powder every day for an additional 4 to 5 weeks. |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2008-05-21
- Last updated
- 2018-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00681512. Inclusion in this directory is not an endorsement.